SEC Form 4
Ginkgo Bioworks Holdings, Inc. (DNA) insider trading
In the 12 months to Oct 26, 2026, 2 DNA insiders reported open-market sales of $71.5K across 2 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $71.5K
- 2 filings · 2 insiders
- Open-market purchases
- $0
- 0 filings
Who traded DNA, and when
- Sale
DNA daily close from Oct 27, 2025 to Oct 26, 2026, between $5.48 and $14.98, last $10.04. 2 sale and 0 purchase filings by 2 insiders, marked at their filing dates. Steven P. Coen, Officer (see filing): sold $36.0K across 1 filing, first filed Oct 7, 2026, last Oct 7, 2026. Christian O. Henry, Director: sold $35.4K across 1 filing, first filed Sep 16, 2026, last Sep 16, 2026.
Largest mark · tap a row for others
Steven P. Coen · Officer (see filing)
Sale $36,045
2,403 shares at $15.00 avg
Filed Oct 7, 2026 · traded Oct 5
Close on filing date $11.47
Steven P. Coen · Officer (see filing)
Officer (see filing)
$36.0K soldChristian O. Henry · Director
Director
$35.4K soldOpen-market trades
2 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Steven P. Coen | Officer (see filing) | $36.0K | — | 1 | — | |
| Christian O. Henry | Director | $35.4K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Steven P. Coen Officer (see filing) | Sale | 2,403 | $15.00 | $36.0K | 49,448 | |
traded | Christian O. Henry Director | Sale | 5,000 | $7.08 | $35.4K | 19,310 |
GET /stocks/filings/vX/form-4?tickers=DNA&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"DNA"
],
"issuer_cik": "0001830214",
"owner_cik": "0001977441",
"accession_number": "0001628280-26-065349",
"form_type": "4",
"filing_date": "2026-10-07",
"period_of_report": "2026-10-05",
"issuer_name": "Ginkgo Bioworks Holdings, Inc.",
"issuer_trading_symbol": "DNA",
"owner_name": "Coen Steven P.",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "See remarks",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-05",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 2403,
"transaction_price_per_share": 15,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 49448,
"transaction_value": 36045,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"
}
],
"remarks": "Chief Financial Officer"
},
{
"tickers": [
"DNA"
],
"issuer_cik": "0001830214",
"owner_cik": "0001263805",
"accession_number": "0001628280-26-062239",
"form_type": "4",
"filing_date": "2026-09-16",
"period_of_report": "2026-09-15",
"issuer_name": "Ginkgo Bioworks Holdings, Inc.",
"issuer_trading_symbol": "DNA",
"owner_name": "HENRY CHRISTIAN O",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-15",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 5000,
"transaction_price_per_share": 7.081,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 19310,
"transaction_value": 35405,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.074 to $7.085, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 59 records
- Option exercises37 records
- Tax withholding (sold to cover)22 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
How current is DNA’s insider data?
These are DNA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track DNA insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for DNA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.